Visitar URL original

Digital Features - Dermatology | Springer Nature Link

Digital Features - Dermatology

Multiple participating journals

A collection of recent articles with digital features such as video abstracts published in the American Journal of Clinical Dermatology, Dermatology & Therapy and Advances in Therapy

Submit your manuscript to this collection through a participating journal.

Advances in Therapy

Journal

Advances in Therapy

Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal.

Submit to this journal Submission guidelines

Dermatology and Therapy

Journal

Dermatology and Therapy

Dermatology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal.

Submit to this journal Submission guidelines

American Journal of Clinical Dermatology

Journal

American Journal of Clinical Dermatology

The American Journal of Clinical Dermatology promotes evidence-based therapy and effective patient management within the discipline of dermatology by publishing critical and...

Submit to this journal Submission guidelines

Showing 1-50 of 119 articles

Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib
Michael DePietro
Leandro L. Santos
Jason A. Brant
in Dermatology and Therapy

Brief Report Open access 08 August 2026 Pages: 4205 - 4216
Cost–Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan
Atsuyuki Igarashi
Koichi Shiraishi
Masakazu Hase
in Dermatology and Therapy

Original Research Open access 04 June 2026 Pages: 3555 - 3575
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review
Jonathan I. Silverberg
Eric Simpson
Justine Alderfer
in Dermatology and Therapy

Review Open access 19 December 2025 Pages: 789 - 806
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
Diamant Thaçi
Akihiko Asahina
Joseph F. Merola
in Dermatology and Therapy

Original Research Open access 12 December 2025 Pages: 953 - 976
Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT
April Armstrong
Kim A. Papp
Diamant Thaçi
in Dermatology and Therapy

Original Research Open access 08 December 2025 Pages: 585 - 603
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
Raymond Matthews
April W. Armstrong
Richard B. Warren
in Dermatology and Therapy

Original Research Open access 22 November 2025 Pages: 499 - 520
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema
David Cohen
Anthony Bewley
Raj Chovatiya
in Dermatology and Therapy

Original Research Open access 15 November 2025 Pages: 423 - 436
Physician-Reported Treatment Patterns in Moderate to Severe Chronic Hand Eczema: the RWEAL Multinational Medical Chart Review
Ana Giménez-Arnau
Anthony Bewley
Sonja Molin
in Dermatology and Therapy

Original Research Open access 26 September 2025 Pages: 3577 - 3592
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?
Eric L. Simpson
Jonathan I. Silverberg
Herwig Koppensteiner
in Dermatology and Therapy

Original Research Open access 23 September 2025 Pages: 3391 - 3407
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis
Sonja Ständer
Gil Yosipovitch
Mike Bastian
in Dermatology and Therapy

Brief Report Open access 19 September 2025 Pages: 3437 - 3446
Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients
Yael A. Leshem
Clara Weil
Robert Lubwama
in Dermatology and Therapy

Brief Report Open access 12 September 2025 Pages: 3425 - 3436
A Global Assessment of Patient Experience and Quality of Life in Generalized Pustular Psoriasis: Results from Interviews and Online Surveys
Lauren C. S. Kole
Yayoi Tada
Gang Wang
in Dermatology and Therapy

Brief Report Open access 07 August 2025 Pages: 3037 - 3053
Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study
April Armstrong
Bruce Strober
Linda Stein Gold
in Dermatology and Therapy

Original Research Open access 06 August 2025 Pages: 2911 - 2923
Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16
Amy S. Paller
Andrew Blauvelt
Eric L. Simpson
in Dermatology and Therapy

Original Research Open access 28 July 2025 Pages: 2879 - 2896
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II
Vivian Y. Shi
John R. Ingram
Jacek C. Szepietowski
in Dermatology and Therapy

Original Research Open access 13 July 2025 Pages: 2553 - 2570
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison
Sonja Ständer
Andreas Pinter
Mike Bastian
in Dermatology and Therapy

Original Research Open access 11 July 2025 Pages: 2537 - 2551
Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling
Beverly Knight
Brinda Tammara
Mario Monshouwer
in Dermatology and Therapy

Original Research Open access 08 July 2025 Pages: 2495 - 2520
Exploring Vitiligo History and Mental Health Burden Among People Within EU5 Countries: Findings from the Global VALIANT Study
Khaled Ezzedine
John E. Harris
Nanja van Geel
in Dermatology and Therapy

Original Research Open access 04 July 2025 Pages: 2439 - 2453
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms
Joseph F. Merola
Philip J. Mease
Alice B. Gottlieb
in Dermatology and Therapy

Brief Report Open access 30 May 2025 Pages: 2281 - 2293
Canadian Consensus Guidelines for the Management of Vitiligo
Vimal H. Prajapati
Harvey Lui
Melinda J. Gooderham
in Dermatology and Therapy

Original Research Open access 20 April 2025 Pages: 1351 - 1369
Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry
Neal Bhatia
Charles W. Lynde
Andrew Korotzer
in Dermatology and Therapy

Brief Report Open access 15 April 2025 Pages: 1523 - 1531
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector
Michael Sebastian
Jerry Bagel
Richard G. Langley
in Dermatology and Therapy

Original Research Open access 29 March 2025 Pages: 1113 - 1134
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions
Kenneth B. Gordon
Yayoi Tada
Diamant Thaçi
in Dermatology and Therapy

Original Research Open access 10 February 2025 Pages: 395 - 411
Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States
Shawn G. Kwatra
Ashis K. Das
Ryan B. Thomas
in Dermatology and Therapy

Original Research Open access 08 February 2025 Pages: 413 - 425
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
Mark Lebwohl
Atul Deodhar
Andrew Blauvelt
in Dermatology and Therapy

Original Research Open access 22 January 2025 Pages: 161 - 188
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials
Joseph F. Merola
Alice B. Gottlieb
Ulrich Mrowietz
in Dermatology and Therapy

Original Research Open access 22 November 2024 Pages: 3291 - 3306
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis
Chien-Chia Chuang
David M. Pariser
Zhixiao Wang
in Dermatology and Therapy

Original Research Open access 21 November 2024 Pages: 3261 - 3271
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
Richard B. Warren
Lev Pavlovsky
Diamant Thaçi
in Dermatology and Therapy

Original Research Open access 08 November 2024 Pages: 3273 - 3290
Evaluation of the Biological Effect of a Nicotinamide-Containing Broad-Spectrum Sunscreen on Photodamaged Skin
Teresa Torres-Moral
Gemma Tell-Martí
Susana Puig
in Dermatology and Therapy

Original Research Open access 07 November 2024 Pages: 3321 - 3336
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
Mark Boguniewicz
Lawrence D. Sher
Ainara Rodríguez Marco
in Advances in Therapy

Original Research Open access 29 October 2024 Pages: 4601 - 4616
Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey
Meredith T. Polaskey
Lakshi Aldredge
Raj Chovatiya
in Dermatology and Therapy

Original Research Open access 28 October 2024 Pages: 3083 - 3095
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Matthias Augustin
Alice B. Gottlieb
Andrew Blauvelt
in Dermatology and Therapy

Original Research Open access 17 September 2024 Pages: 2841 - 2857
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
Jennifer Fu
Alexander Egeberg
Ernest Law
in Dermatology and Therapy

Original Research Open access 10 September 2024 Pages: 2759 - 2769
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
Jonathan I. Silverberg
Andreas Wollenberg
Sonja Ständer
in Dermatology and Therapy

Original Research Open access 10 August 2024 Pages: 2249 - 2260
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis
April W. Armstrong
Andrew F. Alexis
Luke Fostvedt
in Dermatology and Therapy

Original Research Open access 19 June 2024 Pages: 1849 - 1861
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
Eric L. Simpson
Jonathan I. Silverberg
Kanti Chittuluru
in American Journal of Clinical Dermatology

Original Research Article Open access 18 June 2024 Pages: 639 - 654
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
Amy S. Paller
Elaine C. Siegfried
Ashish Bansal
in American Journal of Clinical Dermatology

Original Research Article Open access 14 May 2024 Pages: 655 - 668
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
Eric L. Simpson
Marjolein de Bruin-Weller
Jonathan I. Silverberg
in Dermatology and Therapy

Original Research Open access 03 May 2024 Pages: 1145 - 1160
Herpes Zoster Recurrence: A Narrative Review of the Literature
Raunak Parikh
O’Mareen Spence
Iain Kaan
in Dermatology and Therapy

Review Open access 28 February 2024 Pages: 569 - 592
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
Melinda Gooderham
Ronald Vender
Lawrence Green
in Dermatology and Therapy

Original Research Open access 09 February 2024 Pages: 441 - 451
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis
Hidehisa Saeki
Yoko Kataoka
Kazuhiko Arima
in Dermatology and Therapy

Brief Report Open access 07 February 2024 Pages: 533 - 543
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King
Jennifer Soung
Alexandre Lejeune
in American Journal of Clinical Dermatology

Original Research Article Open access 23 January 2024 Pages: 299 - 314
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft
Ehsanollah Esfandiari
Emma Guttman-Yassky
in American Journal of Clinical Dermatology

Review Article Open access 18 January 2024 Pages: 447 - 461
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Amy S. Paller
Andreas Pinter
Mike Bastian
in Advances in Therapy

Original Research Open access 09 January 2024 Pages: 1046 - 1061
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Eric L. Simpson
Ben Lockshin
Andrew Korotzer
in Dermatology and Therapy

Brief Report Open access 04 January 2024 Pages: 261 - 270
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Eric L. Simpson
Andrew Blauvelt
Andreas Wollenberg
in American Journal of Clinical Dermatology

Original Research Article Open access 07 October 2023 Pages: 139 - 148
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Michael J. Cork
Diamant Thaçi
Noah A. Levit
in Dermatology and Therapy

Original Research Open access 26 September 2023 Pages: 2697 - 2719
Burden of Herpes Zoster Among Patients with Psoriasis in the United States
David Singer
Philippe Thompson-Leduc
Sara Poston
in Dermatology and Therapy

Original Research Open access 22 September 2023 Pages: 2649 - 2668
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Diamant Thaçi
Christos Tziotzios
Ernest Law
in Dermatology and Therapy

Original Research Open access 14 September 2023 Pages: 2621 - 2634
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Jonathan I. Silverberg
April Armstrong
Kristian Reich
in American Journal of Clinical Dermatology

Review Article Open access 11 September 2023 Pages: 913 - 925